Lippis Daniel J. reported option exercise involving 619 derivative units of Edwards Lifesciences Corp at $0.00 for $0 on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CVP, TAVR
CVP, TAVR
Filed Nov 10, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
619Employee Stock Option (Right to Acquire)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,476Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 10, 2026, 4:52 PM ET0-day reporting delay
Accession
0001225208-26-008802Code M · Transaction 397247
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Option exercise619$72.68$44,988.92Trade 397245
Nov 10, 2026Sell619$104.25−$64,530.75Trade 397246
3 transaction rows in this filing. Joint filers share the same rows.

EW price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
EW · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −18%1w ago −8.5%1d ago −1.8%
Returns since7d30d90d180d1y

Footnotes in full

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.